Literature DB >> 22690007

Africa struggles to improve drug safety.

Bernard Appiah.   

Abstract

Mesh:

Year:  2012        PMID: 22690007      PMCID: PMC3394846          DOI: 10.1503/cmaj.109-4199

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Pharmacovigilance in developing countries (part II): a path forward.

Authors:  Shaimaa Elshafie; Anne Marie Roberti; Iman Zaghloul
Journal:  Int J Clin Pharm       Date:  2018-08

2.  African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa.

Authors:  Collet Dandara; Collen Masimirembwa; Yosr Z Haffani; Bernhards Ogutu; Jenniffer Mabuka; Eleni Aklillu; Oluseye Bolaji
Journal:  AAS Open Res       Date:  2019-06-04

3.  Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants.

Authors:  Ronald Kiguba; Charles Karamagi; Paul Waako; Helen B Ndagije; Sheila M Bird
Journal:  BMJ Open       Date:  2014-11-24       Impact factor: 2.692

Review 4.  Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature.

Authors:  Igho J Onakpoya; Carl J Heneghan; Jeffrey K Aronson
Journal:  BMC Med       Date:  2016-02-04       Impact factor: 8.775

5.  Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda.

Authors:  Ronald Kiguba; Paul Waako; Helen B Ndagije; Charles Karamagi
Journal:  Drugs Real World Outcomes       Date:  2015-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.